Augmenting drug–carrier compatibility improves tumour nanotherapy efficacy

A major goal of cancer nanotherapy is to use nanoparticles as carriers for targeted delivery of anti-tumour agents. The drug–carrier association after intravenous administration is essential for efficient drug delivery to the tumour. However, a large number of currently available nanocarriers are se...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yiming, Fay, François, Hak, Sjoerd, Manuel Perez-Aguilar, Jose, Sanchez-Gaytan, Brenda L., Goode, Brandon, Duivenvoorden, Raphaël, de Lange Davies, Catharina, Bjørkøy, Astrid, Weinstein, Harel, Fayad, Zahi A., Pérez-Medina, Carlos, Mulder, Willem J. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833858/
https://www.ncbi.nlm.nih.gov/pubmed/27071376
http://dx.doi.org/10.1038/ncomms11221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4833858/
https://www.ncbi.nlm.nih.gov/pubmed/27071376
http://dx.doi.org/10.1038/ncomms11221

Ejemplares similares